Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy

Genetic risks in breast cancer remain only partly understood. Here we report the results of a genome-wide association study of germline DNA from 4,658 women, including 252 women experiencing a breast cancer recurrence, who were entered on the MA.27 adjuvant trial comparing the aromatase inhibitors (...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Res
Päätekijät: Ingle, James N., Xie, Fang, Ellis, Matthew J., Goss, Paul E., Shepherd, Lois E., Chapman, Judith-Anne W., Chen, Bingshu E., Kubo, Michiaki, Furukawa, Yoichi, Momozawa, Yukihide, Stearns, Vered, Pritchard, Kathleen I., Barman, Poulami, Carlson, Erin E., Goetz, Matthew P., Weinshilboum, Richard M., Kalari, Krishna R., Wang, Liewei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135610/
https://ncbi.nlm.nih.gov/pubmed/27758888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-1371
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia